✦ LIBER ✦

Toxicity Testing: The FDA Perspective

✍ Scribed by JANE E. HENNEY

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dissolution Testing for Generic Drugs: A

✍ Om Anand; Lawrence X. Yu; Dale P. Conner; Barbara M. Davit 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 349 KB

Toxic gas tests in perspective

✍ P. G. Edgerley 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

Endovascular brachytherapy: The FDA's pe

✍ Tara A. Ryan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 190 KB

VARC Consensus Report: The FDA Perspecti

✍ Matthew G. Hillebrenner; Julie A. Swain; Bram Zuckerman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The FDA perspective on the development o

✍ Wilson H. De Camp 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

Invited perspective: In vitro testing in

✍ Kimmel, Gary L. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views